PRECLINICAL STUDIES IDENTIFYING CARBOPLATIN AS A VIABLE CISPLATIN ALTERNATIVE

[11] EHRLICH CE, 1978, P AM ASSOC CANC RES, V19, P379

[12] IMPROVED CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J]. JOURNAL OF UROLOGY, 1977, 117 (01) : 65 - 69

[13] EINHORN LH, 1979, CANCER TREAT REP, V63, P1659

[14] GONZALEZVITALE JC, 1977, CANCER, V39, P1362, DOI 10.1002/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO

[15] 2-N

[16] GOTTLIEB JA, 1975, CANCER CHEMOTH REP 1, V59, P621

[17] Harrap K.R., 1980, CISPLATIN CURRENT ST, P193, DOI 10.1016/B978-0-12-565050-2.50016-4

[18] HARRAP KR, 1983, CANCER CHEMOTHERAPY, V1, P171

[19] HARRAP KR, 1976, EXCERPTA MED AMST, V375, P106

[20] HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO

[11] EHRLICH CE, 1978, P AM ASSOC CANC RES, V19, P379

[12] IMPROVED CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J]. JOURNAL OF UROLOGY, 1977, 117 (01) : 65 - 69

[13] EINHORN LH, 1979, CANCER TREAT REP, V63, P1659

[14] GONZALEZVITALE JC, 1977, CANCER, V39, P1362, DOI 10.1002/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO

[15] 2-N

[16] GOTTLIEB JA, 1975, CANCER CHEMOTH REP 1, V59, P621

[17] Harrap K.R., 1980, CISPLATIN CURRENT ST, P193, DOI 10.1016/B978-0-12-565050-2.50016-4

[18] HARRAP KR, 1983, CANCER CHEMOTHERAPY, V1, P171

[19] HARRAP KR, 1976, EXCERPTA MED AMST, V375, P106

[20] HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO